Skip to main content

Share story

Security Infrastructure

Developer placeholder domain serves fake security check

Developer placeholder domain serves fake security check Image: Primary
The domain third-party.com, used as a placeholder in developer documentation, is serving a fake Cloudflare verification page that tries to make Windows users run a PowerShell command, BleepingComputer confirmed. Unlike domains reserved for examples, third-party.com is a registered address whose content can change. Clicking the page's verification box copies a command to the clipboard; the page then instructs users to paste and run it. The command attempts to download and execute a script. At the time of testing, the payload domain no longer resolved, and there were no reports that documentation links had caused the attack to execute on developers' devices.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from BleepingComputer and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

CISA adds two exploited Check Point flaws to federal fix list

The U.S. Cybersecurity and Infrastructure Security Agency added two Check Point Security Gateway flaws to its list of known exploited vulnerabilities and told federal agencies to apply fixes or mitigations by September 25. Check P...

Security Infrastructure
Security Infrastructure

Analysis identifies two flaws behind exploited MikroTik router takeover chain

CERT Polska has identified the two RouterOS SSH flaws behind a previously reported attack that can give intruders administrative control of exposed MikroTik routers without completing authentication. One flaw lets a connection rea...

Capital AI
Capital AI

Basecamp Research raises $140 million for AI drug development

Basecamp Research announced a $140 million Series C funding round led by S32, with participation from investors including NATO and Nvidia. The company plans to use the capital to advance drug development and pursue more partnershi...